0

ABILIFY از شرکت OTSUKA

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

ABILIFY از شرکت OTSUKA

New Drug Application (NDA): 021436

Company: OTSUKA


Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ABILIFY ARIPIPRAZOLE 10MG TABLET;ORAL Prescription

AB

 Yes Yes
ABILIFY ARIPIPRAZOLE 15MG TABLET;ORAL Prescription

AB

 Yes No
ABILIFY ARIPIPRAZOLE 20MG TABLET;ORAL Prescription

AB

 Yes No
ABILIFY ARIPIPRAZOLE 30MG TABLET;ORAL Prescription

AB

 Yes No
ABILIFY ARIPIPRAZOLE 5MG TABLET;ORAL Prescription

AB

 Yes Yes
ABILIFY ARIPIPRAZOLE 2MG TABLET;ORAL Prescription

AB

 Yes No


Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
11/15/2002 ORIG-1 Approval

Type 1 – New Molecular Entity

STANDARD; Orphan

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21436_Abilify_lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21436ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-436_Abilify.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
02/05/2020 SUPPL-45 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021436Orig1s044, s045; 202971Orig1s013; 207202Orig1s002, s004; 021713Orig1s035, s036; 021729Orig1s027, s028; 021866Orig1s029, s030ltr.pdf
02/05/2020 SUPPL-44 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021436Orig1s044, s045; 202971Orig1s013; 207202Orig1s002, s004; 021713Orig1s035, s036; 021729Orig1s027, s028; 021866Orig1s029, s030ltr.pdf
08/07/2019 SUPPL-43 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021436s043,021713s034,021729s026,021866s028lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021436Orig1s043, 021713Orig1s034, 021729Orig1s026, 021866Orig1s028ltr.pdf
02/23/2017 SUPPL-42 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021436s042,021713s033,021729s025,021866s027lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021436Orig1s042,021713Orig2s033,021729Orig1s025,021866Orig1s027,202971Orig1s011ltr.pdf
08/18/2016 SUPPL-41 Labeling-Package Insert

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021436s041,021713s032,021729s024,021866s026lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021436Orig1s041,021713Orig1s032,021729Orig1s024,021866Orig1s026,202971Orig1s009ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/021436Orig1s041.pdf
01/15/2016 SUPPL-40 Labeling-Package Insert

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/21436s04021713s03121729s02321866s025lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021436Orig1s040,021713Orig1s031,021729Orig1s023,021866Orig1s025,0202971Orig1s008ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/021436Orig1s040.pdf
12/15/2014 SUPPL-39 Manufacturing (CMC)

Label is not available on this site.
12/12/2014 SUPPL-38 Efficacy-New Indication

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021436s038,021713s030,021729s022,021866s023lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021436Orig1s038,021713Orig1s030,021729Orig1s022,021866Orig1s023ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/021436Orig1s038.pdf
07/30/2013 SUPPL-37 Labeling-Medication Guide, Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021436s037,021713s029,021729s021,021866s022lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021436Orig1s037,021713Orig1s029,021729Orig1s021,021866Orig1s022ltr.pdf
06/09/2014 SUPPL-36 Efficacy-Labeling Change With Clinical Data

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021436s036,021866s021,021729s020,021713s028lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/021436Orig1s036,021713Orig1s028,021729Orig1s020,021866Orig1s021ltr.pdf
03/25/2013 SUPPL-35 Manufacturing (CMC)

Label is not available on this site.
02/22/2012 SUPPL-34 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021436s034,021713s025,021729s018,021866s020lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021436s034,021866s020,021713s025,021729s018ltr.pdf
03/02/2011 SUPPL-32 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021436s032,021866s019,021713s024,021729s017lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021436s032,21866s019,21713s024,21729s017ltr.pdf
12/01/2010 SUPPL-31 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021436s031,021866s018,021713s023,021729s016lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021436s031,021866s018,021713s023,021729s016ltr.pdf
11/30/2010 SUPPL-30 Labeling-Medication Guide

Label (PDF)

Letter

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021436s030,021866s017,021713s022,021729s015lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021436s030,021866s017,021713s022,021729s015ltr.pd
02/16/2011 SUPPL-29 Efficacy-New Indication

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021436s029,021713s021,021729s014,021866s016lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021436s029,021729s014,021713s021,021866s016ltr.pdf
07/19/2009 SUPPL-28 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021436s028,021713s020,021729s013,021866s014lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021436s028,021713s020,021729s013,021866s014ltr.pdf
11/19/2009 SUPPL-27 Efficacy-New Indication

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021436s027lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021436s027ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/021436Orig1s027.pdf
08/14/2008 SUPPL-26 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021436s026,021729s012,021713s019,021866s013lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021436s026,021713s019,021729s012,021866s013ltr.pdf
03/06/2008 SUPPL-23 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021436s023,021713s018,021729s010,021866s010ltr.pdf
05/06/2008 SUPPL-22 Labeling

Letter (PDF)

Review (PDF)

Summary Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021436se2-019,021436se1-020,021436s022,021713se2-014.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/NDA/2008/021436Orig1s019_s020_s022.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2008/021436s19s20s22,21713s14s15s017SUMR.pdf
02/27/2008 SUPPL-21 Efficacy-New Patient Population

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021436s21,021713s16,021729s8,021866s8lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021436s021, 021713s016, 021729s008, 021866s008ltr.pdf
05/06/2008 SUPPL-20 Efficacy-New Indication

Letter (PDF)

Review (PDF)

Summary Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021436se2-019,021436se1-020,021436s022,021713se2-014.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/NDA/2008/021436Orig1s019_s020_s022.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2008/021436s19s20s22,21713s14s15s017SUMR.pdf
05/06/2008 SUPPL-19 Efficacy-New Dosing Regimen

Letter (PDF)

Review (PDF)

Summary Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021436se2-019,021436se1-020,021436s022,021713se2-014.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021436Orig1s019_s020_s022.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/summary_review/2008/021436s19s20s22,21713s14s15s017SUMR.pdf
11/16/2007 SUPPL-18 Efficacy-New Indication

Label (PDF)

Letter (PDF)

Review

Summary Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021436s018,021713s013,21729s005,021866s005lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021436s018, 021866s005, 021729s005, 021713s013ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021436s018TOC.cfm

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021436s018_SumR.pdf
10/29/2007 SUPPL-17 Efficacy-New Patient Population

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021436s017,021713s012,21729s004,021866s004lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021436s017, 021713s012, 021729s004, 021866s004ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021436Orig1s017.pdf
09/25/2007 SUPPL-16 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021866s2s3,021729s2,021713s10,021436s16lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021436s016,021713s010,021729s002,021866s3s2ltr.pdf
09/18/2006 SUPPL-14 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021436s014,021713s009lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021436s014, 021713s009ltr.pdf
10/20/2006 SUPPL-13 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021436s013,021713s008,021729s001lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021436s013, 021713s008, 021729s001ltr.pdf
02/16/2006 SUPPL-10 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021436s010,021713s006lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021436s010,021713s006ltr.pdf
03/01/2005 SUPPL-8 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21436s005,008,21713s003lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/21436s005,008,21713s003ltr.pdf
06/21/2005 SUPPL-7 Labeling

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021713s004,021436s007lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021713s004,021436s007ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021436Orig1s007.pdf
04/08/2004 SUPPL-6 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21436slr006_abilify_lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21436slr006ltr.pdf
03/01/2005 SUPPL-5 Efficacy-New Indication

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21436s005,008,21713s003lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/21436s005,008,21713s003ltr.pdf
12/30/2003 SUPPL-4

Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021436_S004_ABILIFY_TABLETS.pdf
09/29/2004 SUPPL-2 Efficacy-New Indication

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21436s002lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21436s002ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/021436Orig1s002.pdf
08/28/2003 SUPPL-1 Efficacy-New Indication

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21436se1-001_abilify_lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21436se1-001ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021436_S001_ABILIFY_TABLETS.pdf


Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert		 Note Url
02/05/2020 SUPPL-45

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf
02/05/2020 SUPPL-44

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021436s044s045,021713s035s036,021729s027s028,021866s029s030lbl.pdf
08/07/2019 SUPPL-43

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021436s043,021713s034,021729s026,021866s028lbl.pdf
02/23/2017 SUPPL-42

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021436s042,021713s033,021729s025,021866s027lbl.pdf
08/18/2016 SUPPL-41

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021436s041,021713s032,021729s024,021866s026lbl.pdf
01/15/2016 SUPPL-40

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/21436s04021713s03121729s02321866s025lbl.pdf
12/12/2014 SUPPL-38

Efficacy-New Indication

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021436s038,021713s030,021729s022,021866s023lbl.pdf
06/09/2014 SUPPL-36

Efficacy-Labeling Change With Clinical Data

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021436s036,021866s021,021729s020,021713s028lbl.pdf
07/30/2013 SUPPL-37

Labeling-Medication Guide

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021436s037,021713s029,021729s021,021866s022lbl.pdf
07/30/2013 SUPPL-37

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021436s037,021713s029,021729s021,021866s022lbl.pdf
02/22/2012 SUPPL-34

Labeling-Package Insert

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021436s034,021713s025,021729s018,021866s020lbl.pdf
03/02/2011 SUPPL-32

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021436s032,021866s019,021713s024,021729s017lbl.pdf
02/16/2011 SUPPL-29

Efficacy-New Indication

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021436s029,021713s021,021729s014,021866s016lbl.pdf
12/01/2010 SUPPL-31

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021436s031,021866s018,021713s023,021729s016lbl.pdf
11/30/2010 SUPPL-30

Labeling-Medication Guide

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021436s030,021866s017,021713s022,021729s015lbl.pdf
11/19/2009 SUPPL-27

Efficacy-New Indication

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021436s027lbl.pdf
07/19/2009 SUPPL-28

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021436s028,021713s020,021729s013,021866s014lbl.pdf
08/14/2008 SUPPL-26

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021436s026,021729s012,021713s019,021866s013lbl.pdf
02/27/2008 SUPPL-21

Efficacy-New Patient Population

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021436s21,021713s16,021729s8,021866s8lbl.pdf
11/16/2007 SUPPL-18

Efficacy-New Indication

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021436s018,021713s013,21729s005,021866s005lbl.pdf
10/29/2007 SUPPL-17

Efficacy-New Patient Population

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021436s017,021713s012,21729s004,021866s004lbl.pdf
09/25/2007 SUPPL-16

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021866s2s3,021729s2,021713s10,021436s16lbl.pdf
10/20/2006 SUPPL-13

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021436s013,021713s008,021729s001lbl.pdf
09/18/2006 SUPPL-14

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021436s014,021713s009lbl.pdf
02/16/2006 SUPPL-10

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021436s010,021713s006lbl.pdf
06/21/2005 SUPPL-7

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021713s004,021436s007lbl.pdf
03/01/2005 SUPPL-8

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21436s005,008,21713s003lbl.pdf
03/01/2005 SUPPL-5

Efficacy-New Indication

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/21436s005,008,21713s003lbl.pdf
09/29/2004 SUPPL-2

Efficacy-New Indication

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21436s002lbl.pdf
04/08/2004 SUPPL-6

Labeling

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21436slr006_abilify_lbl.pdf
08/28/2003 SUPPL-1

Efficacy-New Indication

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21436se1-001_abilify_lbl.pdf
11/15/2002 ORIG-1 Approval

 Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21436_Abilify_lbl.pdf


ABILIFY

TABLET;ORAL; 10MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ABILIFY ARIPIPRAZOLE 10MG TABLET;ORAL Prescription Yes AB 021436 OTSUKA
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 206251 ACCORD HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 206174 AJANTA PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 202101 ALEMBIC PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 207105 ALKEM LABS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 204838 AMNEAL PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 078583 APOTEX INC
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 203908 AUROBINDO PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 091279 BOSCOGEN
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 205064 HETERO LABS LTD V
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 204111 MACLEODS PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 202683 ORCHID HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 205363 PRINSTON INC
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 206383 SCIEGEN PHARMS INC
ARIPIPRAZOLE ARIPIPRAZOLE 10MG TABLET;ORAL Prescription No AB 201519 TORRENT

TABLET;ORAL; 15MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ABILIFY ARIPIPRAZOLE 15MG TABLET;ORAL Prescription Yes AB 021436 OTSUKA
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 206251 ACCORD HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 206174 AJANTA PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 202101 ALEMBIC PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 207105 ALKEM LABS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 204838 AMNEAL PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 078583 APOTEX INC
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 203908 AUROBINDO PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 091279 BOSCOGEN
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 205064 HETERO LABS LTD V
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 204111 MACLEODS PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 202683 ORCHID HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 205363 PRINSTON INC
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 206383 SCIEGEN PHARMS INC
ARIPIPRAZOLE ARIPIPRAZOLE 15MG TABLET;ORAL Prescription No AB 201519 TORRENT

TABLET;ORAL; 20MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ABILIFY ARIPIPRAZOLE 20MG TABLET;ORAL Prescription Yes AB 021436 OTSUKA
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 206251 ACCORD HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 206174 AJANTA PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 202101 ALEMBIC PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 207105 ALKEM LABS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 204838 AMNEAL PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 078583 APOTEX INC
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 203908 AUROBINDO PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 091279 BOSCOGEN
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 205064 HETERO LABS LTD V
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 204111 MACLEODS PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 202683 ORCHID HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 205363 PRINSTON INC
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 206383 SCIEGEN PHARMS INC
ARIPIPRAZOLE ARIPIPRAZOLE 20MG TABLET;ORAL Prescription No AB 201519 TORRENT

TABLET;ORAL; 30MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ABILIFY ARIPIPRAZOLE 30MG TABLET;ORAL Prescription Yes AB 021436 OTSUKA
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 206251 ACCORD HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 206174 AJANTA PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 202101 ALEMBIC PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 207105 ALKEM LABS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 204838 AMNEAL PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 078583 APOTEX INC
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 203908 AUROBINDO PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 091279 BOSCOGEN
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 205064 HETERO LABS LTD V
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 204111 MACLEODS PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 202683 ORCHID HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 205363 PRINSTON INC
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 206383 SCIEGEN PHARMS INC
ARIPIPRAZOLE ARIPIPRAZOLE 30MG TABLET;ORAL Prescription No AB 201519 TORRENT

TABLET;ORAL; 5MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ABILIFY ARIPIPRAZOLE 5MG TABLET;ORAL Prescription Yes AB 021436 OTSUKA
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 206251 ACCORD HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 206174 AJANTA PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 202101 ALEMBIC PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 207105 ALKEM LABS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 204838 AMNEAL PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 078583 APOTEX INC
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 203908 AUROBINDO PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 091279 BOSCOGEN
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 205064 HETERO LABS LTD V
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 204111 MACLEODS PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 202683 ORCHID HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 205363 PRINSTON INC
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 206383 SCIEGEN PHARMS INC
ARIPIPRAZOLE ARIPIPRAZOLE 5MG TABLET;ORAL Prescription No AB 201519 TORRENT

TABLET;ORAL; 2MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ABILIFY ARIPIPRAZOLE 2MG TABLET;ORAL Prescription Yes AB 021436 OTSUKA
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 206251 ACCORD HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 206174 AJANTA PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 202101 ALEMBIC PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 207105 ALKEM LABS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 204838 AMNEAL PHARMS
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 078583 APOTEX INC
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 203908 AUROBINDO PHARMA LTD
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 091279 BOSCOGEN
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 205064 HETERO LABS LTD V
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 204111 MACLEODS PHARMS LTD
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 202683 ORCHID HLTHCARE
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 205363 PRINSTON INC
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 206383 SCIEGEN PHARMS INC
ARIPIPRAZOLE ARIPIPRAZOLE 2MG TABLET;ORAL Prescription No AB 201519 TORRENT
برچسب‌ها:

صفحات پیشنهادی

کلینیک ترک اعتیاد تهران

دکتر مهدی قاضی

متخصص اورولوژی مشهد

دکتر پروستات در مشهد

دکتر زگیل تناسلی در مشهد

وازکتومی در مشهد

مشاهده بیشتر

نظرات کاربران

مشاهده بیشتر

بیماری های روان پزشکی
بیماری های قلب و عروق
زیبایی و سلامت
مطالب آموزشی